Search - tctmd.com

Displaying 441 - 460 of 467

Sort: Relevancy | Date

News Conference News ISET 2016

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

Michael O'Riordan

February 09, 2016

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Features

When Paths Diverge—and Converge: Manish and Sahil Parikh Make Their Mark as Brothers, Clinicians, and Educators

Nicole Lou

August 15, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

News Daily News

Survey Puts Spotlight on Physical Stress of Working in a Cath Lab

February 25, 2015

News Daily News

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

L.A. McKeown

January 12, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

L.A. McKeown

January 12, 2015

News Daily News

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

L.A. McKeown

August 07, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

Advertisement

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

When Paths Diverge—and Converge: Manish and Sahil Parikh Make Their Mark as Brothers, Clinicians, and Educators

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

MVARC Document Offers Template for Mitral Valve Therapeutics Research

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

Survey Puts Spotlight on Physical Stress of Working in a Cath Lab

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content